Valvular Atrial Fibrillation (VAF) is a distinct category of atrial fibrillation that manifests in individuals with significant heart valve disorders. The abnormal electrical signals within the atria, or upper chambers of the heart, lead to irregular and often accelerated heartbeats. The link between VAF and valvular heart diseases, such as mitral stenosis or the presence of a mechanical heart valve, underscores the complexity of this condition. The management of VAF requires a nuanced approach, taking into account both the atrial fibrillation and the underlying valvular pathology. Healthcare professionals navigate treatment strategies based on factors like the severity of the valve disease, the overall health status of the patient, and individual considerations unique to each case. Striking a balance between addressing atrial fibrillation and managing valvular issues is crucial for effective care.
Title : Revolutionizing CKD care: How finerenone transforms outcomes in heart and kidney health - Insights from fidelio-DKD
Robert J Chilton, University of Texas Health Science Center San Antonio, United States
Title : Novel important cellular responses, signaling mechanisms and therapeutic options for pulmonary hypertension and right heart failure
Yong Xiao Wang, Albany Medical Center, United States
Title : Preventing sports-related cardiac arrest: Coronary artery calcium scoring stratifies the benefit of low-dose aspirin use for risk reduction
Arthur J Siegel, Massachusetts General Hospital, United States
Title : Empathy and precision: Revolutionizing communication between cardiologists and patients
Iris Panagiota Efthymiou, University of Greenwich, United Kingdom
Title : Post-cardiotomy ECMO (PC-ECMO)
Gustavo Lionel Knop, Mayo Clinic, United States
Title : The past, present and future of AI in cardiology
Narendra Kumar, HeartbeatsZ Academy, United Kingdom